Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer: how to treat and when?

J Schoenmaekers; Marthe Paats; AMA Dingemans; LEL Hendriks

doi:10.21037/tlcr-20-459

Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer: how to treat and when?

J Schoenmaekers, Marthe Paats, AMA Dingemans, LEL Hendriks

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

3 Downloads (Pure)

Original language	English
Pages (from-to)	2599-2617
Number of pages	19
Journal	Translational Lung Cancer Research
Volume	9
Issue number	6
DOIs	https://doi.org/10.21037/tlcr-20-459
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.21037/tlcr-20-459

Repub_134376_O-A.pdfFinal published version, 768 KB

http://hdl.handle.net/1765/134376

Cite this

@article{70cd514b9316444b878e8134ef8fe3e7,

title = "Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer: how to treat and when?",

author = "J Schoenmaekers and Marthe Paats and AMA Dingemans and LEL Hendriks",

year = "2020",

doi = "10.21037/tlcr-20-459",

language = "English",

volume = "9",

pages = "2599--2617",

journal = "Translational Lung Cancer Research",

issn = "2226-4477",

publisher = "Society for Translational Medicine (STM)",

number = "6",

}